Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/02/2007WO2004052312A3 Anti-infectives
08/02/2007WO2004006841A3 Use of amino acids for treatment of various conditions
08/02/2007US20070180544 Methods and compositions for autism spectrum disorders
08/02/2007US20070179597 Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
08/02/2007US20070179596 Medical Devices, Drug Coatings And Methods for Maintaining the Drug Coatings Thereon
08/02/2007US20070179595 Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
08/02/2007US20070179594 Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
08/02/2007US20070179298 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179197 Compositions and methods for improving or preserving brain function
08/02/2007US20070179196 Methyl 6-(4-fluorobenzyl)-4-hydroxy-3, 5-dioxo-2 , 3,5,6,7, 8-hexahydro-2,6-naphthyridine- 1 -carboxylate; 6-(4-fluorobenzyl)-4-hydroxy-N,N-dimethyl-3 ,5 -dioxo-2,3 ,5 ,6,7,8-hexahydro-2,6-naphthyridine- 1 -carboxamide; HIV, AIDS
08/02/2007US20070179195 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/02/2007US20070179194 Method for the treatment of diabetes
08/02/2007US20070179193 Method for preparing aqueous composition for sterilization
08/02/2007US20070179192 Thrombopoietin mimetics
08/02/2007US20070179191 Oxadiazolones and derivatives thereof as ppar delta agonists
08/02/2007US20070179190 Vla-4 antagonists
08/02/2007US20070179189 Bridged tricyclic (e.g 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases
08/02/2007US20070179188 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/02/2007US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
08/02/2007US20070179186 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
08/02/2007US20070179185 4-(ortho,meta-disubstituted phenyl)-1-alkypiperidines, such as 4-(3-fluoro-2-methylphenyl)-1-propylpiperidine, used for the treatment of nervous system disorders
08/02/2007US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists
08/02/2007US20070179183 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
08/02/2007US20070179182 Chronic neuropathic and visceral pain, adrenergic receptors, side effect reduction; glaucoma or ocular hypertension by topical ophthalmic administration
08/02/2007US20070179181 Treatment of inflammatory disorders and pain using beta-aminoalcohols
08/02/2007US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists
08/02/2007US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
08/02/2007US20070179178 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives
08/02/2007US20070179177 Azaindazoles useful as inhibitors of kinases
08/02/2007US20070179176 Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy
08/02/2007US20070179175 Tetrahydronaphthyridine Derivative
08/02/2007US20070179174 Methods and compositions for slowing aging
08/02/2007US20070179173 Carbostyril compound
08/02/2007US20070179172 Positive modulators of nicotinic acetylcholine receptors
08/02/2007US20070179171 Vinca derivatives
08/02/2007US20070179170 Vinorelbine derivatives
08/02/2007US20070179169 Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
08/02/2007US20070179168 Methods of treating anxiety disorders
08/02/2007US20070179167 Inhibitors of serine proteases
08/02/2007US20070179166 Reduction of statin ketoesters and purification of diol esters of the statins through selective crystallization; rosuvastatin; HMG-CoA inhibitors
08/02/2007US20070179165 Cyclic compounds
08/02/2007US20070179164 Compounds for modulating TRPV3 function
08/02/2007US20070179163 Process for the preparation of risperidone
08/02/2007US20070179162 Triazolopyrimdines
08/02/2007US20070179161 Pyrazolopyrimidine compounds and their use in medicine
08/02/2007US20070179160 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer
08/02/2007US20070179159 1-(3,4,5-trimethoxy-phenyl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; 1-(2-hydroxy-4-methoxy-5-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; inhibits tubulin polymerization in a cell; cancer
08/02/2007US20070179158 2,6-Disubstituted piperiddines as modulators
08/02/2007US20070179157 Nonnucleoside reverse transcriptase inhibitors
08/02/2007US20070179156 3-(isoquinolin-1-ylamino)-5-(6-(methylamino)pyrazin-2-yl)pyridin-2(1H)-one; autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease
08/02/2007US20070179155 N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
08/02/2007US20070179154 Coumarin derivatives, process for their production and use thereof
08/02/2007US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
08/02/2007US20070179152 Combination therapy for the treatment of neoplasms
08/02/2007US20070179151 (1-Isopropyl-6-methoxy-isoquinolin-3-yl)-(5-methyl-1H-pyrazol-3-yl)-amine; (5-Cyclopropyl-1H-pyrazol-3-yl)-(1-isopropyl-6,7-dimethoxy-isoquinolin-3-yl)-amine; Aurora kinase inhibitors; cancer
08/02/2007US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use
08/02/2007US20070179149 4-(4-fluoro-benzyl)-5-oxo-7-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-4,5-dihydro-thieno[3,2-b]pyridine-6-carboxylic acid ethyl ester; antitumor, angiogenesis antagonist; antitumor, antiinflammatoy agent; indirect inhibition of cytokines, growth factors, chemokines, and lymphokines
08/02/2007US20070179148 Piperazinyl derivatives as modulators of chemokine receptor activity
08/02/2007US20070179147 Methods of treating and preventing Alzheimer's disease
08/02/2007US20070179146 2-{4-[3-(3,4-dimethoxy-phenyl)-5.5-dimethyl-6-oxa-5,6-dihydro-4H-pyridazin-1-yl]-piperidine-1-sulfonyl}-benzonitrile; low toxicity, high bioavailability, side effects reduction; antiinflammatory agents; antiallergenic; respiratory disorders
08/02/2007US20070179145 Methotrexate orotate; improve bioavailability and drug clearance thereby reducing toxicity in cancer patients and in non-infectious, non-neoplastic inflammatory conditions such as rheumatoid arthritis, psoriasis, systemic lupus, and multiple sclerosis
08/02/2007US20070179144 5(Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
08/02/2007US20070179143 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070179141 Therapeutic agents useful for treating pain
08/02/2007US20070179140 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity
08/02/2007US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases
08/02/2007US20070179138 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
08/02/2007US20070179137 Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives
08/02/2007US20070179136 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
08/02/2007US20070179135 Cannabinoid derivatives
08/02/2007US20070179134 Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them
08/02/2007US20070179133 Compositions useful as inhibitors of protein kinases
08/02/2007US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/02/2007US20070179131 Novel M3 Muscarinic Acetylcholine Receptor Antagonists
08/02/2007US20070179130 c-MET MODULATORS AND METHOD OF USE
08/02/2007US20070179129 Opioid receptor antagonists
08/02/2007US20070179128 vasopressin receptor antagonists; useful as therapeutics in or prophylactics against conditions such as aggression, obsessive-compulsive disorders, hypertension, dysmenorrhea, hyponatremia, congestive heart failure/cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, etc.
08/02/2007US20070179127 Sulfonamide compound
08/02/2007US20070179126 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
08/02/2007US20070179125 Aminopyrimidines useful as kinase inhibitors
08/02/2007US20070179124 Substituted Porphyrins
08/02/2007US20070179123 Methods and compositions for treating diseases associated with pathogenic proteins
08/02/2007US20070179122 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
08/02/2007US20070179121 Method of treating pediatric patients with corticosteroids
08/02/2007US20070179120 Hydroxyl compounds and compositions for cholesterol management and related uses
08/02/2007US20070179119 new amorphous forms Boniva; x-ray reflections at about 4.6, 9.2, 18.3; x-ray reflections at about 6.2, 25.9, 26.7, 31.1, and 37.2+-0.2 degrees 2 theta; x-ray reflections at about 6.2, 15.7, 26.3, 32.6, and 35.6 +-0.2 degrees 2 theta; desired flowability, rate of dissolution; bone disorders
08/02/2007US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example
08/02/2007US20070179117 Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery
08/02/2007US20070179116 Fused Pentacyclic Polyethers
08/02/2007US20070179115 Purinenucleoside derivative modified in 8-position and medical use thereof
08/02/2007US20070179114 Novel 2'-C methyl nucleoside derivatives
08/02/2007US20070179105 Method and means for treating solid tumors
08/02/2007US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents
08/02/2007US20070179099 Methods of cholesterol reduction using isoflavones
08/02/2007US20070179098 Use of asimadoline hydrochloride
08/02/2007US20070179097 GnRH agonist combination drugs
08/02/2007US20070179096 Pharmaceutical Formulation
08/02/2007US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders
1 ... 3643 3644 3645 3646 3647 3648 3649 3650 3651 3652 3653 3654 3655 3656 3657 3658 3659 3660 3661 3662 3663 ... 7860